Adam Cunningham

Professor of Functional Immunity @ImmunologyUoB @BactiVac

[Adam Cunningham @AFC_immuno]

Now online @medrxivpreprint. Work linking #SARS_CoV_2 to PIMS-TS (#Kawasaki like) in kids. https://t.co/8ercxMjXyx @AlexRichter3 @BarneyUoB @Bham_Childrens
@bIGIdeas_UoB @BHPComms @unibirm_MDS @ImmunologyUoB @unibirmingham @DHSCgovuk @UKgovGHS #Covid_19

[Adam Cunningham @AFC_immuno]

Fanrastic opportunity to join @calmaclenn group @JennerInstitute to work on gonococcal #vaccine project

[BactiVac Network @BactiVac]

📢#JOBALERT @JennerInstitute @UniofOxford are #hiring Postdoctoral Scientist to join the Gonococcal #vaccine Project to investigate the basis of #Immunity against gonorrhoea in man. Apply before 7 April 2021. https://t.co/w7oajR4KUW @calmaclenn

[Adam Cunningham @AFC_immuno]

We are committed to working collaboratively with LMICs & want to say a huge thank you to @bIGIdeas_UoB @unibirmingham for their financial support that has made this all possible. @TheBindingSite @AlexRichter3 @unibirm_MDS @Immunology_UCT @ImmunologyUoB @BHPComms @IMIBirmingham

[Uni of Birmingham @unibirmingham]

Working together with @TheBindingSite, we've shipped #COVID19 antibody testing kits to Cape Town to support the Red Cross Children’s Hospital in the diagnosis of PIMS-TS. Wishing all the best to @Immunology_UCT and thank you to Dr Kate Webb for letting us know they've arrived!

[Adam Cunningham @AFC_immuno]

Great to be supporting our colleagues @Immunology_UCT to do this important work to diagnose PIMS-TS in children using the #COVID19 #antibodytest @unibirmingham have developed with @TheBindingSite. @bIGIdeas_UoB @unibirm_MDS @BHPComms @ImmunologyUoB @IMIBirmingham

[Professor Alex Richter @AlexRichter3]

Our COVID-19 antibody kits have arrived in Cape Town to support the Red Cross Children’s Hospital in the diagnosis of PIMS-TS. Wishing you all the best @Immunology_UCT @TheBindingSite @AFC_immuno

[David Wraith 💙 @cameron_wraith]

This is such an important advance in COVID-19 antibody testing. The use of dried blood spot will allow accurate home testing and seroprevalence studies in LMIC countries. Congrats to a fantastic team @AlexRichter3 @AFC_immuno @ImmunologyUoB

[Adam Cunningham @AFC_immuno]

Lovely new paper in @J_Immunol from @MilernaLain & the group shows how IFNg & T-bet work in Th1 responses to Salmonella to keep bacteria in iNOS+ granulomas. Well done all for great work. @ImmunologyUoB @unibirm_MDS @BactiVac https://t.co/bVXHlKYmqT

[Adam Cunningham @AFC_immuno]

Great to highlight the @unibirmingham approach to #COVID19 antibody testing & our fantastic collaboration with @TheBindingSite during @ASollowayUK visit. Our highly sensitive #ELISA test will be commercially available in July @AlexRichter3 @unibirm_MDS @bIGIdeas_UoB @BHPComms

[College of Medicine and Health (UoB) @unibirm_CMH]

Thank you for visiting, @ASollowayUK; we trust that you enjoyed finding out more about the exciting work that Dr Alex Richter, Professor Andrew Beggs, Professor Adam Cunningham and colleagues are carrying out to support the #COVID19 response.

@AlexRichter3 @adbeggs @AFC_immuno

[Adam Cunningham @AFC_immuno]

Fantastic to be part of such a great team & developing a more reliable test to detect low levels of Ab in asymptotic/mild disease. Also, important to look at both saliva & serum Ab to determine #SARSCoV2 exposure @AlexRichter3 @CrispinMax @bIGIdeas_UoB @BHPComms @unibirm_MDS

[Professor Alex Richter @AlexRichter3]

The Birmingham approach to developing a COVID antibody test using spike protein. Getting great results. @AFC_immuno @SianJossi @sfaustini @MilernaLain @CrispinMax @ImmunologyUoB https://t.co/ATuh3JWR7u

[UniBirmingham News @news_ub]

📰 | A Birmingham designed test, developed by a team led by Dr Alex Richter (@AlexRichter3) and Professor Adam Cunningham (@AFC_immuno) has confirmed #COVID19 as a trigger for a new Kawasaki-like syndrome in children

https://t.co/z7WU3fNeUw @unibirm_MDS

[Uni of Birmingham @unibirmingham]

#COVID19 📢 A test developed by experts here in Birmingham confirms COVID-19 as trigger for a rare Kawasaki-like syndrome in children. Read more about the work from Dr Alex Richter @AlexRichter3 & Professor Adam Cunningham @AFC_immuno here ⬇️
https://t.co/tTx5hJUnOO

[College of Medicine and Health (UoB) @unibirm_CMH]

#COVID19 | Dr Alex Richter (@AlexRichter3) and Prof Adam Cunningham (@AFC_immuno), working with @BWC_NHS, @uhbtrust, @CrispinMax and @TheBindingSite, have developed a test confirming that COVID-19 can be a trigger for #Kawasaki-like syndrome in children: https://t.co/K5TfG6eqKd

[Immunology and Immunotherapy @ImmunologyUoB]

A test developed by experts at @unibirmingham has offered evidence confirming #COVID19 to be the cause of a newly emerged multi-system inflammatory syndrome in children, who have tested negative for the virus by the PCR test.
https://t.co/yp3efOxQe7
@AlexRichter3 @AFC_immuno

[Adam Cunningham @AFC_immuno]

The @TheBindingSite is aiming to have CE mark in place in the next couple months. @AlexRichter3 @bIGIdeas_UoB @unibirm_MDS @ImmunologyUoB @BHPComms @britsocimm

[Adam Cunningham @AFC_immuno]

This is a really great development. The next step in this collaboration with @TheBindingSite. Very humbling to see this test help make a difference to what we know about our immune response to the #COVIDー19 virus @bIGIdeas_UoB @ImmunologyUoB @britsocimm @unibirm_MDS @BHPComms

[Professor Alex Richter @AlexRichter3]

First collaborative COVID19 antibody kits arriving from @TheBindingSite. Time to start a comprehensive validation focussing on detection in those that have had mild disease. @ImmunologyUoB @AFC_immuno @SianJossi @sfaustini @MilernaLain @immunologydoc @TBSsteharding

[Adam Cunningham @AFC_immuno]

Important paper supported by @BactiVac. Helps lay roadmap for much needed new vaccine to gonococcus. Huge cause of infertility & #AMR problem. Great start & well done! @UKgovGHS @unibirm_MDS @DrBroadstock @BHPComms @bIGIdeas_UoB @ImmunologyUoB @britsocimm @WHO

[BactiVac Network @BactiVac]

Great to see @BactiVac's support acknowledged in this paper published in Vaccine on 'Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation' https://t.co/ULizAzXHWo. @unibirm_MDS @AFC_immuno @DrBroadstock

[Adam Cunningham @AFC_immuno]

Great to hear @AlexRichter3 on @BBCr4today talking about how the @unibirmingham team are developing #antibodytest sensitive enough to detect #COVIDー19 in saliva samples making home testing in the #community a real possibility. #FightCOVID19 @unibirm_MDS @bIGIdeas_UoB

[College of Medicine and Health (UoB) @unibirm_CMH]

#COVID19 | Dr Alex Richter (@AlexRichter3; Director, Clinical Immunology Service) spoke to @BBCTomFeilden this morning on the Today Programme. Listen from 2:48:56 and find out more about the antibody tests that @unibirmingham are developing: https://t.co/mFhsTCSBwh #r4today

[Adam Cunningham @AFC_immuno]

Looking forward to participating in this @bIGIdeas_UoB #webinar & talking about developing #antibody tests to detect #COVIDー19 infections & how we can use them to understand & #FightCOVID19 disease @AlexRichter3 @cameron_wraith @unibirm_MDS @IMIBirmingham @CrispinMax

[Uni of Birmingham @unibirmingham]

What does living with the #COVID19 pandemic mean, what role are our research teams playing in the fight & what can we learn for the future? Join us live on Facebook on May 21 for the first in a series of panel events chaired by Prof Hisham Mehanna ⬇️
https://t.co/fMuYsjdP4E

[Barney Scholefield 🌈 💙 @BarneyUoB]

#PIMSTS data in children emerging. Really important role of #COVID19 antibody testing in #pedsicu shock diagnosis.

New realm of #PREPRINT research with lab science colleagues. Great collaboration @uhbtrust @unibirmingham @BWC_NHS @BacrUob @AFC_immuno Full paper to follow

[Adam Cunningham @AFC_immuno]

First ever tweet & about a virus, ironic. New preprint from @unibirmingham 8 kids with PIMS/#KawasakiDisease-like, all #PCR-ve & strong #COVID19 Ab+ve. Prob means infected wks ago, controlled virus, disease tragic side-effect of imm sys working @AlexRichter3 @BarneyUoB @The_MRC